Skandinaviska Enskilda Banken (SEB)
FLGT icon

Skandinaviska Enskilda Banken (SEB)’s Fulgent Genetics FLGT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-38,750
Closed -$2.11M – 947
2022
Q2 		$2.11M Sell
38,750
-96,099
-71% -$5.28M 0.02% 564
2022
Q1 		$8.42M Sell
134,849
-144,026
-52% -$9.48M 0.05% 301
2021
Q4 		$28.3M Buy
278,875
+258,700
+1,282% +$22.7M 0.15% 139
2021
Q3 		$1.81M Sell
20,175
-114,335
-85% -$10.4M 0.01% 668
2021
Q2 		$12.4M Buy
134,510
+55,594
+70% +$4.44M 0.08% 248
2021
Q1 		$7.63M Buy
78,916
+44,348
+128% +$4.58M 0.05% 315
2020
Q4 		$1.8M Buy
+34,568
New +$1.44M 0.01% 679

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s FLGT Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 38,750 shares — an estimated $2.11M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in FLGT in Q4 2020 and held it in 7 quarters. The position peaked at $28.3M in Q4 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 38,750 Fulgent Genetics shares in Q3 2022, an estimated $2.11M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Fulgent Genetics in Q4 2020 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Fulgent Genetics position peaked at $28.3M in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.